S&P 500 6,574.30 -0.14%

道瓊工業平均指數 46,480.80 -0.33%

Nasdaq 100 23,992.70 -0.18%

Russell 2000 2,523.24 +0.33%

富時100指數 10,461.00 +0.26%

日經225指數 53,263.50 -1.71%

Nasdaq 成分指數即時上漲：因中東緊張局勢推升油價，市場回檔下跌

JPMorgan Income ETF (JPIE) delivers a current dividend yield of 5.71% with a 127-basis-point premium over the 10-year Treasury through a diversified portfolio of 34.5% agency mortgage-backed securities, 14.4% cash, 11.6% commercial mortgage-backed securities, 11% high-yield corporate bonds, and 10.2% asset-backed securities, all managed with a short 2.15-year average duration to minimize interest rate sensitivity.

The fund’s income declines as the Fed cuts rates because its short-duration strategy continuously reinvests maturing securities at lower prevailing yields, with monthly distributions falling from approximately $0.23 in 2024 to $0.20 in early 2026.

Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.(Sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© bigjom jom / Shutterstock.com

JPMorgan Income ETF (NYSEARCA:JPIE) has delivered over 50 consecutive monthly distributions since its October 2021 inception, and yet most investors who hold it have never seen the share price move more than a few dollars. That stability is not a flaw. It is the entire point.

A Paycheck from the Bond Market’s Overlooked Corners JPIE solves a specific problem: generating consistent income from debt markets without locking investors into long-duration bonds that bleed value when rates rise. The fund invests opportunistically across a wide variety of debt securities with high potential for attractive risk-adjusted income and low correlations to each other, with a secondary objective of capital appreciation. That mandate gives the managers flexibility to go where the yield is.

The return engine is spread income across a diversified mix of fixed income sectors. Agency mortgage-backed securities make up 34.5% of the portfolio, followed by cash and equivalents at 14.4%, commercial mortgage-backed securities at 11.6%, high-yield corporate bonds at 11%, and asset-backed securities at 10.2%. The remaining allocation spans non-agency MBS, emerging market dollar-denominated debt, and investment-grade corporates. This is an actively managed income fund designed to capture yield wherever JPMorgan’s fixed income team sees the best yield relative to credit risk.

Duration management is central to the strategy. The fund’s average duration sits at just 2.15 years, keeping it far less sensitive to interest rate swings than a typical intermediate bond fund. More than half the portfolio matures within three years, giving managers room to reinvest at prevailing rates as conditions change.

What the Income Actually Looks Like The fund’s current dividend yield is 5.71%, with a 30-day SEC yield of 5.64% and a yield to maturity of 5.76%. Against a 10-year Treasury yield of 4.44%, JPIE offers a 127-basis-point premium over the 10-year Treasury for taking on credit and structural complexity rather than pure duration risk.

Monthly distributions have been consistent, though they have declined gradually as short-term rates have fallen. The 2024 average distribution ran approximately $0.23 per month, while 2025 averaged closer to $0.21, and 2026 year-to-date payments have come in at $0.20821 in March and $0.20359 in February. The trend reflects falling short-term rates: the Fed has cut its target rate from 4.50% in September 2025 to 3.75% today, compressing yields on the short-duration securities that dominate this portfolio.

JPIE has returned 5.56% over the past year, and 15.24% since inception in late 2021. That figure includes reinvested distributions. An investor who bought at launch and reinvested every monthly payment has earned modestly positive real returns in an environment that crushed most bond funds. The Bloomberg US Aggregate Index lost roughly 13% in 2022 during the rate-hiking cycle. JPIE’s short duration insulated it from the worst of that damage.

The Tradeoffs Worth Understanding Declining distributions as rates fall: The fund’s short average duration means it continuously reinvests at current rates. When the Fed cuts, JPIE’s income follows. Investors expecting a fixed monthly check will see it shrink in easing cycles, as the 2024-to-2026 distribution trend confirms. Credit complexity and concentration in structured products: Nearly 55% of the portfolio carries a AAA rating, largely from agency MBS. But roughly 18.5% sits in BB or lower-rated bonds, and 10.8% is unrated. In a credit stress event, these positions could widen significantly, pressuring both distributions and net asset value. Limited capital appreciation potential: JPIE’s share price sits near $45.94 today, up from $39.86 at inception. Price appreciation is minimal by design. Investors who need their portfolio to grow in real terms alongside income should not rely on this fund for that growth. JPIE is structured as a core income sleeve for conservative investors or retirees who want monthly cash flow, protection from interest rate duration risk, and broad fixed income diversification managed by an active team. Investors focused on capital gains will find little of it here, and those counting on a fixed monthly payment should factor in that the check will shrink when the Fed eases.

About the Author Michael Williams →

Top Gaining Stocks

SBA Communications SBAC Vol: 946,266

• $11.51
• 6.71% $183.07

New Pluto Global PSKY Vol: 8,215,993

• $0.38
• 4.05% $9.63

DoorDash DASH Vol: 3,164,008

• $5.95
• 3.95% $156.45

Intel INTC Vol: 90,532,020

• $1.72
• 3.57% $49.75

LyondellBasell Industries LYB Vol: 4,903,857

• $2.66
• 3.47% $79.37

Top Losing Stocks

Enphase Energy ENPH Vol: 3,517,610

• $2.72 7.11% $35.56

Tesla TSLA Vol: 59,205,878

• $20.93 5.49% $360.34

Carnival CCL Vol: 18,606,126

• $1.10 4.12% $25.49

Bristol Myers Squibb BMY Vol: 7,217,160

• $2.41 3.90% $59.32

Packaging Corp of America PKG Vol: 474,640

• $8.19 3.87% $203.09